Dr. Hanni Salih, M.D.
What this data tells you about Dr. Salih
Dr. Hanni Salih is a medical oncology specialist in San Antonio, TX, with 13 years of NPI registration. Based on federal Medicare data, Dr. Salih performed 30,785 Medicare services across 1,825 unique beneficiaries.
Between the years covered by Open Payments, Dr. Salih received a total of $11,310 from 74 pharmaceutical and/or device companies across 448 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Salih is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) | 24,750 | $1 | $3 |
| Dexamethasone injection (steroid) | 1,026 | $0 | $0 |
| Comprehensive metabolic blood panel | 645 | $10 | $32 |
| Complete blood count (CBC) with differential | 572 | $8 | $23 |
| Office visit, established patient (30-39 min) | 492 | $92 | $373 |
| Blood draw (venipuncture) | 485 | $8 | $16 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 273 | $22 | $86 |
| Administration of chemotherapy into vein, 1 hour or less | 226 | $98 | $376 |
| Complete blood count (CBC), automated | 169 | $6 | $19 |
| Lactate dehydrogenase (enzyme) level | 165 | $6 | $18 |
| Ferritin level test (iron stores) | 153 | $13 | $41 |
| Iron level test | 143 | $6 | $19 |
| Iron binding capacity test | 143 | $9 | $26 |
| Hospital follow-up visit, moderate complexity | 133 | $60 | $231 |
| Drug injection, under skin or into muscle | 118 | $11 | $47 |
| Injection of additional new drug or substance into vein | 110 | $12 | $58 |
| Administration of chemotherapy into vein, each additional hour | 99 | $21 | $90 |
| Carcinoembryonic antigen (cea) protein level | 98 | $18 | $57 |
| Administration of additional new drug or substance into vein, 1 hour or less | 97 | $47 | $205 |
| Magnesium level test | 86 | $7 | $20 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 84 | $49 | $185 |
| Infusion, normal saline solution , 1000 cc | 78 | $2 | $19 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 75 | $340 | $1,342 |
| Office visit, established patient, complex (40-54 min) | 64 | $123 | $523 |
| Infusion into a vein for hydration, 31-60 minutes | 63 | $25 | $137 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 | 53 | $20 | $62 |
| Immunoglobulin level test | 51 | $9 | $28 |
| Free thyroxine (T4) test | 47 | $9 | $27 |
| New patient office visit (45-59 min) | 47 | $123 | $486 |
| Office visit, established patient (20-29 min) | 47 | $64 | $263 |
| Infusion into a vein for hydration, each additional hour | 43 | $10 | $42 |
| Vitamin B-12 level test | 37 | $15 | $45 |
| C-reactive protein test (inflammation marker) | 25 | $5 | $16 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 21 | $20 | $62 |
| Prothrombin time test (blood clotting) | 20 | $4 | $13 |
| Uric acid level test | 18 | $4 | $14 |
| New patient office visit, complex (60-74 min) | 16 | $172 | $641 |
| Red blood count, automated test | 13 | $4 | $12 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (69%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Salih is a mixed practice specialist, with above-average Medicare volume (top 30% in TX), with low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Salih experienced with iron infusion (injectafer)?
Does Dr. Salih receive payments from pharmaceutical companies?
How do Dr. Salih's costs compare to other medical oncologists in San Antonio?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology